Invitrocue
Healthcare Services · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Hildegardstraße 9, Munich, Bavaria, 8053...Phone Number
+49 89998209480Website
www.invitrocue.comRevenue
<$5 MillionStock Symbol
IVQIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
2
2
1
About Invitrocue
Invitrocue is a leading provider of personalized oncology and bio-analytics solutions, specializing in personalized cancer testing, in vitro cell-based testing technologies, and image analytics software. The company has developed a unique 3D cell-based scaffolding technology that allows for the culture of patient-derived cancer cells to support clinical decision-making. Their Onco-PDO test utilizes patients' own cancer cells to identify the most effective treatment options by testing them against a panel of approved chemotherapy drugs. Invitrocue serves patients, healthcare providers, scientists, and researchers, focusing on personalized treatment and safety and efficacy testing.Explore more
Invitrocue Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Invitrocue your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Invitrocue recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Invitrocue
Check if Invitrocue has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Invitrocue has new funding data
Product Launch: Get notified when Invitrocue launches new products
Click to see if Invitrocue had a recent Job posting/layoffs
Check out if Invitrocue is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Invitrocue, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Invitrocue
Compare insights from companies similar to Invitrocue, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Invitrocue is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Invitrocue is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Invitrocue.
Invitrocue Tech Stack
A closer look at the technologies used by Invitrocue
See more technologies
Invitrocue News & Media
Some Invitrocue (ASX:IVQ) Shareholders Are Down 45%
Investors can approximate the average market return by buying an index fund. While individual stocks can be big...Is Invitrocue Limited's (ASX:IVQ) CEO Being Overpaid?
The CEO of Invitrocue Limited (ASX:IVQ) is Steven Fang. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Then we'll look at a snap shot of the business g...Do Institutions Own Invitrocue Limited (ASX:IVQ) Shares?
The big shareholder groups in Invitrocue Limited (ASX:IVQ) have power over the company. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. Read More...
Read more news
Top Healthcare Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Invitrocue
Sign Up For FreeTo access detailed company insights
Invitrocue is a leading provider of personalized oncology and bio-analytics solutions, specializing in personalized cancer testing, in vitro cell-based testing technologies, and image analytics software. The company has developed a unique 3D cell-based scaffolding technology that allows for the culture of patient-derived cancer cells to support cli... Read More
